“…Until recently, all African Burkitt's lymphoma biopsies studied had been shown to contain EBV genomes by EBNA staining (31) and/or nucleic acid hybridization (33,34 (12,13). The similarity of these nonendemic cases to those of African origin gained credibility when it was found that some patients had elevated serum antibody titers to EBV (8,9) and that tumor cells from an AmBL patient had B cell characteristics (6). However, with the introduction of more stringent techniques for the detection of EBV-specific DNA (33) or nuclear antigens (24), studies of AmBL biopsies have consistently revealed the absence of demonstrable EBV genomes (10,11).…”